Volume 14 Supplement 2
Practical guide for allergy and immunology in Canada 2018
An extensive update to the prominent and widely-popular Practical Guide for Allergy and Immunology in Canada published in 2011, this broad-ranging supplement is designed to provide all healthcare professionals with a comprehensive, yet easy-to-follow, series of peer-reviewed articles focussed on all of the common conditions dealt with in the field of allergy and immunology.
Edited by Harold Kim, Richard Warrington and Wade Watson
Publication of this supplement has been supported by AstraZeneca, Boehringer Ingelheim, CSL Behring Canada Inc., MEDA Pharmaceuticals Ltd., Merck Canada Inc., Pfizer Canada Inc., Shire Pharma Canada ULC, Stallergenes Greer Canada, Takeda Canada, Teva Canada Innovation, Aralez Tribute and Pediapharm. The articles have undergone the journal's standard peer review process for supplements. All Supplement Editors confirm they were not involved in the review process of papers that they are listed as authors.
The official journal of CSACI
2017 Journal Metrics
68 days to first decision for reviewed manuscripts only
63 days to first decision for all manuscripts
145 days from submission to acceptance
15 days from acceptance to publication
604 Altmetric Mentions